InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (17 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
17
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Mirviss Jeffrey B., Vice-Président Exécutif et Président, Interventions Périphériques. Director active across 1 company, notably Boston Scientific CORP. Aggregated, 44 disclosures have been logged. Split: 0 buy · 17 sells. Total volume traded: €6.2m. History available since 27 July 2021. The latest transaction was disclosed on 24 February 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Mirviss Jeffrey B.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations44 total
4,675 shares@ US$104.255.7% of flowCommon StockSEC:0001225208-25-002386:0
1,510 shares@ US$105.351.9% of flowCommon StockSEC:0001225208-25-001970:0
2,776 shares0Common StockSEC:0001225208-25-001874:0
2,115 shares0Common StockSEC:0001225208-25-001793:0
23,760 shares0Common StockSEC:0001225208-25-001685:0
10,430 shares0Common StockSEC:0001225208-25-000206:0
33,726 shares@ US$17.266.6% of flowCommon StockSEC:0001225208-24-006445:0
14,506 shares@ US$66.450410.9% of flowCommon StockSEC:0001225208-24-004316:0
4,960 shares@ US$66.353.8% of flowCommon StockSEC:0001225208-24-002707:0
2,970 shares0Common StockSEC:0001225208-24-002577:0
2,776 shares0Common StockSEC:0001225208-24-002306:0
26,666 shares0Common StockSEC:0001225208-24-001781:0
15,172 shares@ US$16.312.8% of flowCommon StockSEC:0001225208-24-000738:0
15,000 shares@ US$16.312.8% of flowCommon StockSEC:0001225208-24-000467:0
11,931 shares@ US$57.8217.8% of flowCommon StockSEC:0001225208-24-000380:0
17,439 shares0Common StockSEC:0001225208-24-000109:0
353 shares@ US$55.030.2% of flowCommon StockSEC:0001225208-23-010827:0
649 shares0Common StockSEC:0001225208-23-010679:0
4,000 shares0Common StockSEC:0001225208-23-010129:0
13,971 shares@ US$53.148.5% of flowCommon StockSEC:0001225208-23-008555:0
4,903 shares@ US$50.402.8% of flowCommon StockSEC:0001225208-23-004745:0
4,903 shares@ US$49.602.7% of flowCommon StockSEC:0001225208-23-004332:0
2,804 shares0Common StockSEC:0001225208-23-002532:0
2,970 shares0Common StockSEC:0001225208-23-002378:0
2,031 shares0Common StockSEC:0001225208-23-002154:0
25 of 44 declarations
About Mirviss Jeffrey B.
Mirviss Jeffrey B. is Vice President Executive and President, Peripheral Interventions at Boston Scientific CORP. He has 44 filings, all in the tracked sample, with EUR 6,232,721 of sales and EUR 0 of purchases, from 2016-01-05 to 2025-02-25; the most common transaction type is Option exercise.
